Giraudon , I., Abel-Ollo, K., Vanaga-Arāja, D., Heudtlass, P., . and Griffiths, P., N. (2024). Nitazenes represent a growing threat to public health in Europe. The Lancet Public Health, 9, (4), pp. e216. doi:10.1016/S2468-2667(24)00024-0 [RJ] View web page
Soderholm, A., Mansfield, D., Groshkova, T., Sedefov, R. and Griffiths, P., N. (2024). Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countries. Addiction, 119, (6), pp. 1021-1023. doi:10.1111/add.16496 [RJ] View web page
Griffiths, P., N., Seyler, T., ., De Morais, J., M., Mounteney, J. and Sedefov, R. (2023). Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future. Addiction, 119, (8). doi:10.1111/add.16420 [RJ] View web page
Singleton, N., ., Cunningham, A., Groshkova, T., Royuela, L., ., Sedefov, R. and Griffiths, P., N. (2023). Using Supply Indicators in the Evaluation of Drug Supply Reduction – Challenges and Opportunities. In Rossi, C. and Conti, S. (eds.) Evaluating the impact of Laws Regulating Illicit Drugs on Health and Society. Bentham Science Publisher. pp. 134-152. doi:10.2174/9789815079241123010012 [CH] View web page
Lorenzetti, V., Hindocha, C., Petrilli, K., ., Griffiths, P., N., Brown, J., ., Castillo-Carniglia, Á., ., Caulkins, J., P., Englund, A., ., Elsohly, M., A., Gage, S., H., Groshkova, T., Gual, A., ., Hammond, D., Lawn, W., Lopez, H., ., Manthey, J., Mokrysz, C., ., Liccardo Pacula, R., ., Van Laar, M., Vandrey, R., ., Wadsworth, E., ., Winstock, A., R., Hall, W., Curran, H., V. and Freeman, T., P. (2022). The iCannToolkit: a consensus‐based, flexible framework for measuring contemporary cannabis use. Addiction, 117, (9), pp. 2558-2560. doi:10.1111/add.15956 [RJ] View web page
Lorenzetti, V., Hindocha, C., Petrilli, K., ., Griffiths, P., N., Brown, J., ., Castillo-Carniglia, Á., ., Caulkins, J., P., Englund, A., ., Elsohly, M., A., Gage, S., H., Groshkova, T., Gual, A., ., Hammond, D., Lawn, W., Lopez, H., ., Manthey, J., Mokrysz, C., ., Pacula, R., Van Laar, M., Vandrey, R., ., Wadsworth, E., ., Winstock, A., R., Hall, W., Curran, H., V. and Freeman, T., P. (2022). The iCannToolkit: a tool to embrace measurement of medicinal and non‐medicinal cannabis use across licit, illicit and cross‐cultural settings. Addiction, 117, (6), pp. 1523-1525. doi:10.1111/add.15855 [RJ] View web page
Pirona, A., Matias, J., Montanari, L., Škařupová, K., Ferri, M., ., Giraudon , I., Mounteney, J., Sleiman, S., ., Natoniewska, K., ., Guarita, B., ., Vandam, L., ., Surmont, T. and Griffiths, P., N. (2022). Impact of COVID-19 on drug markets, use, harms and drug services in Europe. Journal of Geography Politics and Society, 12, (1). doi:10.26881/jpgs.2022.1.02 [RJ] View web page
Schneider, E., Bronzwaer, S., ., Catchpole, M., Cockburn, W., de Coen, W., Foltz, C., Goodey, J., ., Griffiths, P., N., Herold, R., ., Ikomonou, D., ., Jepsen, M., ., Raineri, A., ., Reingardé, J., . and Uhel, R., . (2022). Learning from the COVID-19 experience: Strengthening EU-ANSA Agencies' cooperation and preparedness to support evidence-based policymaking in times of crisis. Publications Office of the European Union. ISBN: 978-92-9499-407-3 doi:10.2805/402212 [T] View web page
Ferri, M., . and Griffiths, P., N. (2021). Good Practice and Quality Standards. In el-Guebaly, N., Carrà, G., Galanter, M. and Baldacchino, A. (eds.) Textbook of Addiction Treatment. pp. 783-800. doi:10.1007/978-3-030-36391-8_54 [CH] View web page
Griffiths, P., N., Mounteney, J. and Sedefov, R. (2021). The same fundamental drivers but differently expressed: what can we learn from comparing the recent experiences with synthetic opioids in the US and Europe? Addiction, 116, (6), pp. 1314-1316. doi:10.1111/add.15340 [RJ] View web page
Groshkova, T., Liem, M., ., Cunningham, A., Sedefov, R. and Griffiths, P., N. (2021). Drug-related violence: Will COVID-19 drive better data for safer and more secure EU? International Journal of Drug Policy, 93. doi:10.1016/j.drugpo.2021.103143 [RJ] View web page
Guarita, B., 2., Běláčková, V., van der Gouwe, D., Blankers, M., Pazitny, M., . and Griffiths, P., N. (2021). Monitoring drug trends in the digital environment–New methods, challenges and the opportunities provided by automated approaches. International Journal of Drug Policy, 94. doi:10.1016/j.drugpo.2021.103210 [RJ] View web page
Hughes, B., Vandam, L., ., Mounteney, J. and Griffiths, P., N. (2021). Regulatory approaches to cannabidiol in the European Union: are market developments sowing the seeds of confusion? Addiction, 117, (1), pp. 3-4. doi:10.1111/add.15587 [RJ] View web page
Lorenzetti, V., Hindocha, C., Petrilli, K., ., Griffiths, P., N., Brown, J., ., Castillo-Carniglia, Á., ., Caulkins, J., P., Englund, A., ., Elsohly, M., A., Gage, S., H., Groshkova, T., Gual, A., ., Hammond, D., Lawn, W., Lopez, H., ., Manthey, J., Mokrysz, C., ., Pacula, R., Van Laar, M., Vandrey, R., ., Wadsworth, E., ., Winstock, A., R., Hall, W., Curran, H., V. and Freeman, T., P. (2021). The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use. Addiction, 117, (6), pp. 1510-1517. doi:10.1111/add.15702 [RJ] View web page
Seyler, T., ., Giraudon , I., Noor, A., Mounteney, J. and Griffiths, P., N. (2021). Is Europe facing an opioid epidemic: What does European monitoring data tell us? European Journal of Pain, 25, (5), pp. 1072-1080. doi:10.1002/ejp.1728 [RJ] View web page
Groshkova, T., Stoian, T., ., Cunningham, A., Griffiths, P., N., Singleton, N., . and Sedefov, R. (2020). Will the Current COVID-19 Pandemic Impact on Long-term Cannabis Buying Practices? Journal of Addiction Medicine, 14, (4), pp. e13-e14. doi:10.1097/ADM.0000000000000698 [RJ] View web page
Degenhardt, L., Wolfe, D., ., Hall, W., Hickman, M., Chang, J., Bruneau, J., ., Farrell, M. and Griffiths, P., N. (2019). Strategies to reduce drug-related harm: responding to the evidence base. The Lancet, 394, (10208), pp. 1490-1493. doi:10.1016/S0140-6736(19)32232-9 [RJ] View web page
Ferri, M., ., Mounteney, J. and Griffiths, P., N. (2019). Low-risk drinking guidelines: a pragmatic approach to health promotion? Addiction, 114, (4), pp. 605-607. doi:10.1111/add.14532 [RJ] View web page
Freeman, T., P., Groshkova, T., Cunningham, A., Sedefov, R., Griffiths, P., N. and Lynskey, M. (2019). Increasing potency and price of cannabis in Europe, 2006‐2016. Addiction, 114, (6), pp. 1015-1023. doi:10.1111/add.14525 [RJ] View web page
Hines, L., Trickey, A., Leung, J., Larney, S., Peacock, A., Degenhardt, L., Colledge-Frisby, S., Hickman, M., Grebely, J., Cunningham, E., B., Stone, J., Dumchev, K., Griffiths, P., N., Vickerman, P., Mattick, R. and Lynskey, M. (2019). Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis. The Lancet Global Health, 8, (1), pp. e76-e91. doi:10.1016/S2214-109X(19)30462-0 [RJ] View web page
Leung, J., Peacock, A., Colledge-Frisby, S., Grebely, J., Cunningham, E., B., Hickman, M., Vickerman, P., Stone, J., Trickey, A., Dumchev, K., Lynskey, M., Hines, L., Griffiths, P., N., Mattick, R., Degenhardt, L. and Larney, S. (2019). A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs—Do Gender-Based Differences Vary by Country-Level Indicators? The Journal of Infectious Diseases, 220, (1), pp. 78-90. doi:10.1093/infdis/jiz058 [RJ] View web page
Leung, J., Peacock, A., Colledge-Frisby, S., Grebely, J., Cunningham, E., B., Hickman, M., Vickerman, P., Stone, J., Trickey, A., Dumchev, K., Lynskey, M., Hines, L., Griffiths, P., N., Mattick, R., Degenhardt, L. and Larney, S. (2019). A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators? The Journal of Infectious Diseases, 220, (1), pp. 78-90. doi:10.1093/infdis/jiz058 [RJ] View web page
Mounteney, J. and Griffiths, P., N. (2019). Monitoring Trends: Use of Local Data. In Slobodin, O., Petras, H., Robertson, E. and Hingson, R. (eds.) Prevention of Substance Use. Springer Nature. pp. 223-232. doi:10.1007/978-3-030-00627-3_14 [CH] View web page
Mounteney, J., Griffiths, P., N., Sedefov, R. and Evans-Brown, M. (2019). Fentanils: a serious threat to public health. Addiction, 114, (5), pp. 783-785. doi:10.1111/add.14542 [RJ] View web page
Peacock, A., Bruno, R., Gisev, N., Degenhardt, L., Hall, W., Sedefov, R., White, J., Thomas, K., V., Farrell, M. and Griffiths, P., N. (2019). New psychoactive substances: challenges for drug surveillance, control, and public health responses. The Lancet, 394, (10209), pp. 1668-1684. doi:10.1016/S0140-6736(19)32231-7 [RJ] View web page
Singleton, N., ., Ballotta, D., Costa Storti, C., Quigley, E., Vandam, L., . and Griffiths, P., N. (2019). Getting real: Lessons learnt from the EMCDDA’s experience of supporting real life policy evaluations. Journal of Addiction Research and Practice, 65, (5). doi:10.1024/0939-5911/a000627 [RJ] View web page
Catchpole, M., Cockburn, W., Comby, B., Deluyker, H., Eichler, H., Goodey, J., ., Griffiths, P., N., Hugas, M., ., Ikomonou, D., ., Knight, D., Mezger, E., Mortensen, L., Murphy, T., Needham, H., Purser, S., Ranieri, A., Schmidt-Abbey, B., Stanners, D. and Szcześniak, A. (2018). EU–ANSA agencies' engagement in the European Union research knowledge cycle: an overview. Publications Office of the European Union. ISBN: 978-92-9499-054-9 doi:10.2805/32422 [T] View web page
Freeman, T., P., Van der Pol, P., Kuijpers, W., Wisselink , J., Das, R., K., Rigter, S., Van Laar, M., Griffiths, P., N., Swift, W., Niesink , R. and Lynskey, M. (2018). Changes in cannabis potency and first-time admissions to drug treatment: A 16-year study in the Netherlands. Psychological Medicine, 48, (14). doi:10.1017/S0033291717003877 [RJ] View web page
Griffiths, P., N., Quigley, E., Vandam, L., . and Mounteney, J. (2018). The challenge of responding to a more globally joined-up, dynamic, and innovative drug market: Reflections from the EMCDDA's 2018 analysis of the European drug situation. Dusunen Adam Journal of Psychiatry and Neurological Sciences, 31, (3), pp. 231-237. doi:10.5350/DAJPN20183103001 [RJ] View web page
Hughes, B., Matias, J. and Griffiths, P., N. (2018). Inconsistencies in the assumptions linking punitive sanctions and use of cannabis and new psychoactive substances in Europe. Addiction, 113, (12), pp. 2155-2157. doi:10.1111/add.14372 [RJ] View web page
Kraus, L., Seitz, N., Piontek, D., Molinaro, S., Siciliano, V., Guttormsson, U., Arpa, S., Monshouwer, K., Leifman, H., Vicente, J., Griffiths, P., N., Clancy, L., Feijão, F., Florescu, S., Lambrecht, P., Nociar, A., Raitasalo, K., Spilka , S., Vyshinskiy, K. and Hibell , B. (2018). 'Are The Times A-Changin'? Trends in adolescent substance use in Europe. Addiction, 113, (7), pp. 1317-1332. doi:10.1111/add.14201 [RJ] View web page
Laniel , L., Gandilhon, M., Adès, J., Cunningham, A., Singleton, N., ., Sedefov, R. and Griffiths, P., N. (2018). EMCDDA Papers Captagon: Understanding today's illicit market. Publications Office of the European Union. ISBN: 978-92-9497-349-8 doi:10.2810/855785 [T] View web page
Peacock, A., Leung, J., Larney, S., Colledge-Frisby, S., Hickman, M., Rehm, J., Giovino, G., A., West, R., Hall, W., Griffiths, P., N., Ali, R., L., Gowing, L., R., Marsden, J., Ferrari, A., J., Grebely, J., Farrell, M. and Degenhardt, L. (2018). Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction, 113, (10), pp. 1905-1926. doi:10.1111/add.14234 [RJ] View web page
Pirona, A., Matias, J., Giraudon , I., Montanari, L., Mounteney, J., Surmont, T., Laniel , L., Wcisło, A., Bo, A., Christie, R., Jekabsone, I., Škařupová, K., Singleton, N., . and Griffiths, P., N. (2018). Results from an EMCDDA trendspotter study Recent changes in Europe's cocaine market. Publications Office of the European Union, Luxembourg. doi:10.2810/49990 [T] View web page
Szcześniak, A., Goodey, J., ., Stanners, D., Ikomonou, D., ., Mortensen, L., Mezger, E., Comby, B., Griffiths, P., N., Purser, S., Hugas, M., ., Murphy, T., Ranieri, A., Catchpole, M., Schmidt-Abbey, B., Cockburn, W., Needham, H., Eichler, H., Knight, D. and Deluyker, H. (2018). Approaches to assess and manage scientific uncertainty: examples from EU ANSA agencies. European Food Safety Authority. ISBN: 978-92-9499-059-4 doi:10.2805/936107 [T] View web page
Degenhardt, L., Peacock, A., Colledge-Frisby, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E., B., Trickey, A., Dumchev, K., Lynskey, M., Griffiths, P., N., Mattick, R., Hickman, M. and Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. The Lancet Global Health, 5, (12), pp. e1192-e1207. doi:10.1016/S2214-109X(17)30375-3 [RJ] View web page
Hughes, B., Wiessing , L., Des Jarlais , D., C. and Griffiths, P., N. (2017). Could cannabis liberalisation lead to wider changes in drug policies and outcomes? International Journal of Drug Policy, 51, pp. 156-159. doi:10.1016/j.drugpo.2017.10.004 [RJ] View web page
Larney, S., Peacock, A., Leung, J., Colledge-Frisby, S., Hickman, M., Vickerman, P., Grebely, J., Dumchev, K., Griffiths, P., N., Hines, L., Cunningham, E., B., Mattick, R., Lynskey, M., Marsden, J., Strang, J. and Degenhardt, L. (2017). Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. The Lancet Global Health, 5, (12), pp. e1208-e1220. doi:10.1016/S2214-109X(17)30373-X [RJ] View web page
Lynskey, M., Morley, K., Griffiths, P., N., Gossop, M., Powis, B. and Strang, J. (2017). The relationship between initial route of heroin administration and speed of transition to daily heroin use. Drug and Alcohol Review, 36, (5), pp. 633-638. doi:10.1111/dar.12560 [RJ] View web page
Mounteney, J., Cunningham, A., Groshkova, T., Sedefov, R. and Griffiths, P., N. (2017). Looking to the future-more concern than optimism that cryptomarkets will reduce drug-related harms: Commentary. Addiction, 113, (5), pp. 799-800. doi:10.1111/add.14056 [RJ] View web page
Mounteney, J., Griffiths, P., N., Bo, A., Cunningham, A., Matias, J. and Pirona, A. (2017). Nine reasons why ecstasy is not quite what it used to be. International Journal of Drug Policy, 51, pp. 36-41. doi:10.1016/j.drugpo.2017.09.016 [RJ] View web page
Mounteney, J., Ruiz, M., J., Bo, A., Groshkova, T., Matias, J., Vandam, L., ., Cardoso, F., Christie, R., Montanari, L., Giraudon , I. and Griffiths, P., N. (2017). High-risk drug use and new psychoactive substances. Results from an EMCDDA trendspotter study. Publications Office of the European Union. ISBN: 978-92-9497-118-0 doi:10.2810/583405 [T] View web page
Wiessing , L., Ferri, M., ., Běláčková, V., Carrieri, P., Friedman, S., R., Folch, C., Dolan, K., Galvin, B., Vickerman, P., Lazarus, J., V., Mravčík, V., Kretzschmar, M., Sypsa, V., Sarasa-Renedo, A., Uusküla, A., Paraskevis, D., Mendão, L., Rossi, D., van Gelder , N., Mitcheson, L., Paoli , L., Diaz Gomez, C., Milhet, M., Dascalu, N., Knight, J., Hay, G., Kalamara, E., Simon, R., Comiskey, C., Rossi, C. and Griffiths, P., N. (2017). Monitoring quality and coverage of harm reduction services for people who use drugs: A consensus study. Harm Reduction Journal, 14, (19). doi:10.1186/s12954-017-0141-6 [RJ] View web page
Wiessing , L., Ferri, M., ., Darke, S., Simon, R. and Griffiths, P., N. (2017). Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studies. Drug and Alcohol Review, 37, (1), pp. S323-S338. doi:10.1111/dar.12608 [RJ] View web page
Mounteney, J., Oteo Pérez, A. and Griffiths, P., N. (2016). The internet and drug markets: shining a light on these complex and dynamic systems. In Mounteney, J., Bo, A. and Oteo Pérez, A. (eds.) The internet and drug markets. Publications Office of the European Union. doi:10.2810/324608 [CH] View web page